Impact of cytomegalovirus infection on biliary disease after liver transplantation - maybe an essential factor

Table 2 Demographics and clinical characteristics comparisons by biliary complications in adults

	Patients with biliary complications (n = 28)	Patients without biliary complications (n = 10)	P value
Age (yr)	49.3 (37.8-57.5)	51.6 (40.6-54.5)	0.619
Sex (M/F)	19/9	10/0	0.079
Primary disease (adult)			0.047
Liver failure	3	0
Decompensated liver cirrhosis	14	10
HCC	9	0
Other	2	0
MELD	14.6 ± 6.8	15 ± 5.5	0.63
Liver transplantation			1
LDLT	1	0
DDLT	25	10
Cross-assisted liver transplantation	2	0
Cold ischemia time (min)	477.9 ± 193.7	582.1 ± 150.9	0.208
Warm ischemia time (min)	5 (3.25-5)	5 (5-7)	0.069
Biliary reconstruction (Duct-to-duct/Roux-en-Y)	16/2	9/1	0.927
Blood CMV status (P/N)	6/22	2/8	1
Biliary CMV status (P/N)	10/18	0/10	0.038
Rejection (Yes/No)	3/16	1/9	0.667
HAT (Yes/No)	1/18	0/10	0.46
Outcome (alive/died)	25/3	10/0	0.552

HCC: Hepatocellular carcinoma; LDLT: Living donor liver transplantation; DDLT: Deceased donor liver transplantation; CMV: Cytomegalovirus; HAT: Hepatic artery thrombosis; MELD: Model for end-stage liver disease; M: Male; F: Female; P: Positive; N: Negative.